{"id":347114,"date":"2026-03-15T06:37:19","date_gmt":"2026-03-15T06:37:19","guid":{"rendered":"https:\/\/www.newsbeep.com\/ie\/347114\/"},"modified":"2026-03-15T06:37:19","modified_gmt":"2026-03-15T06:37:19","slug":"combinations-of-colistin-and-bacteriocins-prevent-the-selection-of-colistin-resistance-in-acinetobacter-baumannii","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ie\/347114\/","title":{"rendered":"Combinations of colistin and bacteriocins prevent the selection of colistin resistance in Acinetobacter baumannii"},"content":{"rendered":"

Gigante, V. et al. Multi-year analysis of the global preclinical antibacterial pipeline: trends and gaps. Antimicrob. Agents Chemother. 68, e0053524 (2024).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

GBD 2021 Antimicrobial Resistance Collaborators Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050. Lancet 404, 1199\u20131226 (2024).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Murray, C. J. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629\u2013655 (2022).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Sati, H. et al. The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance. Lancet Infect. Dis. 25, 1033\u20131043 (2025).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

M\u00fcller, C. et al. A global view on carbapenem-resistant Acinetobacter baumannii. mBio 14, e02260-23 (2023).<\/p>\n

Wenzler, E., Goff, D. A., Humphries, R. & Goldstein, E. J. C. Anticipating the unpredictable: a review of antimicrobial stewardship and acinetobacter infections. Infect. Dis. Ther. 6, 149\u2013172 (2017).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Bostanghadiri, N. et al. Prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: a systematic review and meta-analysis. Antimicrob. Resist. Infect. Control 13, 24 (2024).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Mohamed, Y. F., Abou-Shleib, H. M., Khalil, A. M., El-Guink, N. M. & El-Nakeeb, M. A. Membrane permeabilization of colistin toward pan-drug resistant Gram-negative isolates. Braz. J. Microbiol. 47, 381\u2013388 (2016).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Sabnis, A. et al. Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane. eLife 10, 1\u201326 (2021).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Aghapour, Z. et al. Molecular mechanisms related to colistin resistance in Enterobacteriaceae. Infect. Drug Resist. 12, 965\u2013975 (2019).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Moffatt, J. H. et al. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob. Agents Chemother. 54, 4971\u20134977 (2010).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Moffatt, J. H. et al. Insertion sequence ISAba11 is involved in colistin resistance and loss of lipopolysaccharide in Acinetobacter baumannii. Antimicrob. Agents Chemother. 55, 3022\u20133024 (2011).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Dahdouh, E. et al. A novel mutation in pmrB mediates colistin resistance during therapy of Acinetobacter baumannii. Int J. Antimicrob. Agents 49, 727\u2013733 (2017).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Seleim, S. M., Mostafa, M. S., Ouda, N. H. & Shash, R. Y. The role of pmrCAB genes in colistin-resistant Acinetobacter baumannii. Sci. Rep. 12, 20951 (2022).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Lin, M.-F., Lin, Y.-Y. & Lan, C.-Y. Contribution of EmrAB efflux pumps to colistin resistance in Acinetobacter baumannii. J. Microbiol. 55, 130\u2013136 (2017).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Tyers, M. & Wright, G. D. Drug combinations: a strategy to extend the life of antibiotics in the 21st century. Nat. Rev. Microbiol. 17, 141\u2013155 (2019).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Shields, R. K. et al. High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen. Diagn. Microbiol Infect. Dis. 70, 246\u2013252 (2011).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Wareham, D. W. & Bean, D. C. In-vitro activity of polymyxin B in combination with imipenem, rifampicin and azithromycin versus multidrug resistant strains of Acinetobacter baumannii producing OXA-23 carbapenemases. Ann. Clin. Microbiol. Antimicrob. 5, 10 (2006).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Pankuch, G. A., Lin, G., Seifert, H. & Appelbaum, P. C. Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii. Antimicrob. Agents Chemother. 52, 333\u2013336 (2008).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Guelfi, K. C. et al. In vitro evaluation of the antimicrobial activity of meropenem in combination with polymyxin B and gatifloxacin against Pseudomonas aeruginosa and Acinetobacter baumannii. J. Chemother. 20, 180\u2013185 (2008).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Wang, X. et al. Colistin-phage combinations decrease antibiotic resistance in Acinetobacter baumannii via changes in envelope architecture. Emerg. Microbes Infect. 10, 2205\u20132219 (2021).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Sugrue, I., Ross, R. P. & Hill, C. Bacteriocin diversity, function, discovery and application as antimicrobials. Nat. Rev. Microbiol. 22, 556\u2013571 (2024).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Soltani, S. et al. Bacteriocins as a new generation of antimicrobials: toxicity aspects and regulations. FEMS Microbiol. Rev. 45, fuaa039 (2021).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Telhig, S., Ben Said, L., Zirah, S., Fliss, I. & Rebuffat, S. Bacteriocins to Thwart Sbacterial resistance in gram negative bacteria. Front. Microbiol. 11, 586433 (2020).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Cotter, P. D., Ross, R. P. & Hill, C. Bacteriocins – A viable alternative to antibiotics? Nat. Rev. Microbiol 11, 95\u2013105 (2013).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Naghmouchi, K. et al. Synergistic effect between colistin and bacteriocins in controlling Gram-negative pathogens and their potential to reduce antibiotic toxicity in mammalian epithelial cells. Antimicrob. Agents Chemother. 57, 2719\u20132725 (2013).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Chi, H. & Holo, H. Synergistic antimicrobial activity between the broad spectrum bacteriocin garvicin KS and nisin, farnesol and polymyxin B against gram-positive and gram-negative bacteria. Curr. Microbiol. 75, 272\u2013277 (2018).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Thomas, V. M., Brown, R. M., Ashcraft, D. S. & Pankey, G. A. Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii. Int. J. Antimicrob. Agents 53, 663\u2013668 (2019).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Jahangiri, A. et al. Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates. Micro. Pathog. 150, 104700 (2021).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Brunati, C. et al. Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells. J. Antimicrob. Chemother. 73, 414\u2013424 (2018).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Mortzfeld, B. M., Bhattarai, S. K. & Bucci, V. Novel class IIb microcins show activity against Gram-negative ESKAPE and plant pathogens. Elife 13, RP102912 (2024).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Valcek, A. et al. Phenotypic Characterization and Heterogeneity among Modern Clinical Isolates of Acinetobacter baumannii. Microbiol. Spectr. 11, e0306122 (2023).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Jacobs, A. C. et al. AB5075, a highly virulent isolate of acinetobacter baumannii, as a model strain for the evaluation of pathogenesis and antimicrobial treatments. mBio 5, 10\u20131128 (2014).<\/p>\n

Ayoub Moubareck, C. & Hammoudi Halat, D. Insights into acinetobacter baumannii: a review of microbiological, virulence, and resistance traits in a threatening nosocomial pathogen. Antibiotics 9, 119 (2020).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Iwatani, S., Zendo, T., Yoneyama, F., Nakayama, J. & Sonomoto, K. Characterization and structure analysis of a novel bacteriocin, lacticin Z, produced by Lactococcus lactis QU 14. Biosci. Biotechnol. Biochem. 71, 1984\u20131992 (2007).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Cintas, L. M. et al. Enterocins L50A and L50B, two novel bacteriocins from Enterococcus faecium L50, are related to staphylococcal hemolysins. J. Bacteriol. 180, 1988\u20131994 (1998).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Yoneyama, F. et al. Lacticin Q-mediated selective toxicity depending on physicochemical features of membrane components. Antimicrob. Agents Chemother. 55, 2446\u20132450 (2011).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Hofkens, N. et al. Microbisporicin (NAI-107) protects Galleria mellonella from infection with Neisseria gonorrhoeae. Microbiol. Spectr. 11, e0282523 (2023).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Hofkens, N. et al. Protective effect of microbisporicin (NAI-107) against vancomycin resistant Enterococcus faecium infection in a Galleria mellonella model. Sci. Rep. 14, 4786 (2024).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Fujita, K. et al. Structural analysis and characterization of lacticin Q, a novel bacteriocin belonging to a new family of unmodified bacteriocins of gram-positive bacteria. Appl. Environ. Microbiol. 73, 2871\u20132877 (2007).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Liu, X. et al. Identification of an N-terminal formylated, two-peptide bacteriocin from Enterococcus faecalis 710C. J. Agric. Food Chem. 59, 5602\u20135608 (2011).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Acedo, J. Z. et al. Nuclear magnetic resonance solution structures of lacticin Q and aureocin A53 reveal a structural motif conserved among leaderless bacteriocins with broad-spectrum activity. Biochemistry 55, 733\u2013742 (2016).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Yoneyama, F. et al. Lacticin Q, a lactococcal bacteriocin, causes high-level membrane permeability in the absence of specific receptors. Appl. Environ. Microbiol 75, 538\u2013541 (2009).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Yoneyama, F. et al. Peptide-lipid huge toroidal pore, a new antimicrobial mechanism mediated by a lactococcal bacteriocin, lacticin Q. Antimicrob. Agents Chemother. 53, 3211\u20133217 (2009).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Netz, D. J. A., Bastos, M., do, C., de, F. & Sahl, H.-G. Mode of action of the antimicrobial peptide aureocin A53 from Staphylococcus aureus. Appl. Environ. Microbiol. 68, 5274\u20135280 (2002).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Lopalco, P., Stahl, J., Annese, C., Averhoff, B. & Corcelli, A. Identification of unique cardiolipin and monolysocardiolipin species in Acinetobacter baumannii. Sci. Rep. 7, 2972 (2017).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Ushiyama, F. et al. Lead optimization of 2-hydroxymethyl imidazoles as non-hydroxamate LpxC inhibitors: discovery of TP0586532. Bioorg. Med. Chem. 30, 115964 (2021).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Yoshida, I., Takata, I., Fujita, K., Takashima, H. & Sugiyama, H. TP0586532, a novel non-hydroxamate LpxC inhibitor: potentiating effect on in vitro activity of meropenem against carbapenem-resistant Enterobacteriaceae. Microbiol. Spectr. 10, e0082822 (2022).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Simpson, B. W. et al. Acinetobacter baumannii can survive with an outer membrane lacking lipooligosaccharide due to structural support from elongasome peptidoglycan synthesis. mBio 12, e0309921 (2021).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Carretero-Ledesma, M. et al. Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii. Virulence 9, 930\u2013942 (2018).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Kamoshida, G. et al. Lipopolysaccharide-deficient Acinetobacter baumannii due to colistin resistance is killed by neutrophil-produced lysozyme. Front. Microbiol. 11, 573 (2020).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Powers, M. J. & Trent, M. S. Phospholipid retention in the absence of asymmetry strengthens the outer membrane permeability barrier to last-resort antibiotics. Proc. Natl. Acad. Sci. USA 115, E8518\u2013E8527 (2018).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Beceiro, A. et al. Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii. Antimicrob. Agents Chemother. 58, 518\u2013526 (2014).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Boll, J. M. et al. A penicillin-binding protein inhibits selection of colistin-resistant, lipooligosaccharide-deficient Acinetobacter baumannii. Proc. Natl. Acad. Sci. USA 113, E6228\u2013E6237 (2016).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Hernandez-Bird, J. et al. Resistance, heteroresistance, and fitness costs drive colistin treatment failure during Acinetobacter baumannii pneumonia. Proc. Natl. Acad. Sci. USA 123, e2515303123 (2026).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Charretier, Y. et al. Colistin heteroresistance and involvement of the PmrAB regulatory system in Acinetobacter baumannii. Antimicrob. Agents Chemother. 62, e00788\u201318 (2018).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Yau, W. et al. Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme. J. Infect. 58, 138\u2013144 (2009).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Andersson, D. I., Nicoloff, H. & Hjort, K. Mechanisms and clinical relevance of bacterial heteroresistance. Nat. Rev. Microbiol 17, 479\u2013496 (2019).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Novovi\u0107, K. & Jov\u010di\u0107, B. Colistin resistance in Acinetobacter baumannii: molecular mechanisms and epidemiology. Antibiotics 12, 516 (2023).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Veeraraghavan, B. et al. A microbiological and structural analysis of the interplay between sulbactam\/durlobactam and imipenem against penicillin-binding proteins (PBPs) of Acinetobacter spp. Antimicrob. Agents Chemother. 69, e0162724 (2025).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Hashizume, T., Ishino, F., Nakagawa, J., Tamaki, S. & Matsuhashi, M. Studies on the mechanism of action of imipenem (N-formimidoylthienamycin) in vitro: binding to the penicillin-binding proteins (PBPs) in Escherichia coli and Pseudomonas aeruginosa, and inhibition of enzyme activities due to the PBPs in E. coli. J. Antibiot. 37, 394\u2013400 (1984).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Atanaskovic, I. & Kleanthous, C. Tools and approaches for dissecting protein bacteriocin import in gram-negative bacteria. Front. Microbiol. 10, 646 (2019).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Tenaillon, O., Denamur, E. & Matic, I. Evolutionary significance of stress-induced mutagenesis in bacteria. Trends Microbiol. 12, 264\u2013270 (2004).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Pribis, J. P., Zhai, Y., Hastings, P. J. & Rosenberg, S. M. Stress-induced mutagenesis, gambler cells, and stealth targeting antibiotic-induced evolution. mBio 13, e0107422 (2022).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Manuse, S. et al. Bacterial persisters are a stochastically formed subpopulation of low-energy cells. PLoS Biol. 19, e3001194 (2021).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Shan, Y. et al. ATP-dependent persister formation in Escherichia coli. mBio 8, e02267\u201316 (2017).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Edelmann, D. & Berghoff, B. A. A shift in perspective: a role for the type I toxin TisB as persistence-stabilizing factor. Front. Microbiol. 13, 871699 (2022).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

MacNair, C. R. et al. Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics. Nat. Commun. 9, 458 (2018).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Maharramov, E. et al. Exploring the principles behind antibiotics with limited resistance. Nat. Commun. 16, 1842 (2025).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Kaneti, G., Sarig, H., Marjieh, I., Fadia, Z. & Mor, A. Simultaneous breakdown of multiple antibiotic resistance mechanisms in S. aureus. FASEB J. 27, 4834\u20134843 (2013).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Stokes, J. M. et al. Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance. Nat. Microbiol 2, 17028 (2017).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

L\u00e1z\u00e1r, V. et al. Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides. Nat. Microbiol 3, 718\u2013731 (2018).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Blattner, F. R. et al. The complete genome sequence of Escherichia coli K-12. Science 277, 1453\u20131462 (1997).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Gabant, P. & Borrero, J. PARAGEN 1.0: a standardized synthetic gene library for fast cell-free bacteriocin synthesis. Front Bioeng. Biotechnol. 7, 213 (2019).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Lin, Y. et al. Assembly of long error-prone reads using de Bruijn graphs. Proc. Natl. Acad. Sci. USA 113, E8396\u2013E8405 (2016).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Sim\u00e3o, F. A., Waterhouse, R. M., Ioannidis, P., Kriventseva, E. V. & Zdobnov, E. M. BUSCO: assessing genome assembly and annotation completeness with single-copy orthologs. Bioinformatics 31, 3210\u20133212 (2015).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Cuccuru, G. et al. Orione, a web-based framework for NGS analysis in microbiology. Bioinformatics 30, 1928\u20131929 (2014).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Feldgarden, M. et al. AMRFinderPlus and the Reference Gene Catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulence. Sci. Rep. 11, 12728 (2021).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Krawczyk, P. S., Lipinski, L. & Dziembowski, A. PlasFlow: predicting plasmid sequences in metagenomic data using genome signatures. Nucleic Acids Res 46, e35 (2018).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Perrin, A. & Rocha, E. P. C. PanACoTA: a modular tool for massive microbial comparative genomics. NAR Genom. Bioinform. 3, lqaa106 (2021).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Morrissey, I. & Patel, J. B. Modification of antimicrobial susceptibility testing methods. J. Antimicrob. Chemother. 80, 2887\u20132888 (2025).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Cannella, S. E. et al. Stability, structural and functional properties of a monomeric, calcium-loaded adenylate cyclase toxin, CyaA, from Bordetella pertussis. Sci. Rep. 7, 42065 (2017).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Voegele, A. et al. A high-affinity calmodulin-binding site in the CyaA toxin translocation domain is essential for invasion of eukaryotic cells. Adv. Sci. 8, 2003630 (2021).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Subrini, O. et al. Characterization of a membrane-active peptide from the Bordetella pertussis CyaA toxin. J. Biol. Chem. 288, 32585\u201332598 (2013).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n

Sadi, M. et al. B2LiVe, a label-free 1D-NMR method to quantify the binding of amphitropic peptides or proteins to membrane vesicles. Cell Rep. Methods 3, 100624 (2023).<\/p>\n


\n Google Scholar<\/a>\u00a0\n <\/p>\n","protected":false},"excerpt":{"rendered":"Gigante, V. et al. Multi-year analysis of the global preclinical antibacterial pipeline: trends and gaps. Antimicrob. Agents Chemother.…\n","protected":false},"author":2,"featured_media":347115,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[3104,14238,1437,61,60,2137,82],"class_list":["post-347114","post","type-post","status-publish","format-standard","has-post-thumbnail","category-science","tag-antibiotics","tag-antimicrobial-resistance","tag-general","tag-ie","tag-ireland","tag-life-sciences","tag-science"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/347114","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/comments?post=347114"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/posts\/347114\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media\/347115"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/media?parent=347114"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/categories?post=347114"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ie\/wp-json\/wp\/v2\/tags?post=347114"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}